Maiti A, DiNardo CD, Kadia TM, Rausch CR, Pemmaraju N, Daver NG, Borthakur G, Naqvi K, Ohanian M, Short NJ, Alvarado Y, MD, Takahashi K, Yilmaz M, Jain N, Kornblau S, Sasaki K, Andreeff M , Bose P, Ferrajoli A, Issa GC, Jabbour EJ, Masarova L, Thompson PA, Wang S, Konoplev S, Maduike RE, Guerrero JA, Bivins CA, Wade A, Thomas R, Vaughan K, Pierce SA, Ning J, Qiao W, Ravandi F, MD, Garcia-Manero G, Welch JS, Kantarjian HM, Konopleva MY
It means the decision to stop, lower, or space out doses should be planned, monitored, and individualized
You deserve better than risky shots with frightening side effects
Start your intake The Rebound Weight Gain Phenomenon: What Research Shows Weight regain after stopping GLP-1 medications is well-documented and occurs because the medication's appetite-suppressing effects cease
Three scenarios may support lower initial dosing under physician supervision